Three major players join forces on HIV detection:
This article was originally published in Clinica
Executive Summary
Belgian company Innogenetics has joined forces with German diagnostics manufacturers Boehringer Mannheim and Behring to sublicense their HIV-O patents. The three companies have agreed a cross-licensing deal concerning HIV-O. They have awarded sublicenses to Organon Tekuika and Murex and further sublicences are being negotiated.